Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Waiting For Cannabidiol Guidance? US FDA Reminds Industry Of ‘Many Other Requirements’

Sep 23 2020

• By Malcolm Spicer

Joliet, Illinois / USA - December 9, 2018: Medicinal hemp CBD oil packages, capsules and tinctures displayed on a white background

Related Content

FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements

Dec 28 2018

Drug Claims For CBD, Detoxification Supplements Make Warning List Along With Pandemic Fraud

Jun 11 2020

US Bill For CBD Supplement Path Draws Mixed Industry Response

Sep 12 2020

US COVID-19 Fraud: Tincture, Sanitizer Warnings, Criminal Contempt Charges And Civil Settlement

Jul 14 2020

FDA ISO Data On CBD Safety In Supplements, Sees Potential As Well As Risks

Nov 20 2019

Additional Topics

International United States Cannabidiol CBD FDA Dietary Supplements Advertising, Marketing & Sales Business Strategies Commercial Compliance Drug Approval Standards Enforcement Ingredients Guidance Documents Manufacturing Policy Regulation Safety Consumer

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window